1. Home
  2. KMPR vs GENB Comparison

KMPR vs GENB Comparison

Compare KMPR & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kemper Corporation

KMPR

Kemper Corporation

HOLD

Current Price

$26.09

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$16.26

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
KMPR
GENB
Founded
1990
2018
Country
United States
United States
Employees
7400
N/A
Industry
Property-Casualty Insurers
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KMPR
GENB
Price
$26.09
$16.26
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$47.67
$23.20
AVG Volume (30 Days)
1.1M
890.1K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
3.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.35
$16.58
P/E Ratio
$14.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.69
$11.00
52 Week High
$64.96
$16.75

Technical Indicators

Market Signals
Indicator
KMPR
GENB
Relative Strength Index (RSI) 48.05 63.07
Support Level $22.69 $11.73
Resistance Level $26.54 $16.75
Average True Range (ATR) 0.90 1.17
MACD 0.39 0.34
Stochastic Oscillator 86.99 87.34

Price Performance

Historical Comparison
KMPR
GENB

About KMPR Kemper Corporation

Kemper Corp is an insurance holding company that offers complementary insurance products through its subsidiaries, including personal and commercial automobile insurance to consumers in targeted markets and industries. Kemper also offers life and other insurance solutions based on the needs of its clients. The company offers its insurance products through a vast network of agents and brokers, mainly under the Kemper Auto and Kemper Life brands. It has two operating segments: Specialty Property & Casualty Insurance and Life Insurance. The majority of the company's revenue is generated from the Specialty Property & Casualty Insurance segment, whose principal products are specialty personal automobile and commercial automobile insurance. Geographically, it operates only in the United States.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: